Pedersen N C, Morris B
J Exp Med. 1974 Sep 1;140(3):619-30. doi: 10.1084/jem.140.3.619.
Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 h of the graft being finally rejected. Appearance of the antibody See PDF for Structure in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them were similar to those seen in the terminal stages of primary rejection. These findings have led us to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.
具有针对供体淋巴细胞的细胞毒性和凝集活性的抗体通常在原发性肾移植受者的血流中,于移植物最终被排斥后的48小时内出现。抗体在血液中的出现与血管通透性的严重改变相关,这导致来自同种异体移植物的淋巴液中红细胞数量和蛋白质含量增加。从肾移植组织中可以洗脱细胞毒性和凝集抗体,表明这种类型的抗体在排斥过程中与移植抗原结合。输注先前已排斥同种异体移植物的绵羊的全血清或血清球蛋白,会导致近期植入的肾移植物被破坏,这些移植物产生的组织学变化以及来自它们的淋巴液成分改变与原发性排斥终末期所见相似。这些发现使我们得出结论,至少在绵羊中,原发性肾移植排斥的终末期是由体液抗体介导的。